Video Experimental Relacionado
Updated: Jun 25, 2026
10:14
Recapitulation of an Ion Channel IV Curve Using Frequency Components
Published on: February 9, 2011
La mayoría de las mutaciones LQT2 reducen la corriente Kv11.1 (hERG) por un mecanismo de clase 2 (deficiente de
Corey L Anderson1, Brian P Delisle, Blake D Anson
1Department of Medicine, University of Wisconsin-Madison, WI, USA.
Circulation
|January 25, 2006
Resumen
La mayoría de las mutaciones del síndrome de QT largo tipo 2 (LQT2) causan defectos de tráfico en los canales Kv11.1. Este estudio muestra que la reducción de la temperatura o el uso de medicamentos específicos puede corregir estos problemas de tráfico en muchos canales LQT2 Kv11.1.
Área de la Ciencia:
- Genética cardiovascular Genética cardiovascular Genética cardiovascular Genética cardiovascular Genética cardiovascular
- Cardiología Molecular Cardiología Molecular
- Fisiología del canal iónico Fisiología del canal iónico
Sus antecedentes:
- El gen KCNH2 codifica el canal Kv11.1, crucial para la actividad eléctrica cardíaca.
- Las mutaciones en KCNH2 causan el síndrome congénito de QT largo tipo 2 (LQT2), lo que lleva a la pérdida de la función del canal Kv11.1.
- Los mecanismos identificados incluyen defectos en la síntesis de canales, tráfico, puertas o permeación.
Objetivo del estudio:
- Determinar si las mutaciones de mal sentido de LQT2 resultan predominantemente en canales Kv11.1 con deficiencia de tráfico.
- Para investigar si el fenotipo deficiente en tráfico de estos canales mutantes puede corregirse.
Principales métodos:
- Se han expresado canales Kv11.1 de tipo salvaje y 34 canales Kv11.1 mutantes de mal sentido LQT2 en células HEK293.
- Utilizó el análisis de Western blot para evaluar el tráfico de canales.
- Corrección probada de los defectos del tráfico utilizando la temperatura reducida (27 ° C) y medicamentos específicos (E4031, tapsigargina).
Principales resultados:
- 28 de las 34 mutaciones LQT2 exhibieron un fenotipo deficiente en tráfico (clase 2).
- El defecto de tráfico de clase 2 se corrigió en la mayoría de estos mutantes mediante la reducción de la temperatura o el tratamiento farmacológico.
- Cuatro mutaciones mostraron tráfico de tipo salvaje, pero no perjudicaron la función del canal, lo que sugiere que son variantes raras.
Conclusiones:
- Los defectos de tráfico de clase 2 son un mecanismo dominante para la disfunción del canal Kv11.1 en LQT2.
- El fenotipo deficiente en tráfico de muchos canales mutantes LQT2 es corregible.
- El desarrollo de terapias dirigidas a las anomalías del tráfico de proteínas puede beneficiar a los pacientes con LQT2.
Videos de Conceptos Relacionados
01:24Non-gated Ion Channels
Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
01:26Voltage-gated Ion Channels
Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
01:24Non-gated Ion Channels
Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:26Voltage-gated Ion Channels
Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...